Meitav Dash Investments LTD Neuro Sense Therapeutics Ltd. Transaction History
Meitav Dash Investments LTD
- $6.32 Billion
- Q2 2025
A detailed history of Meitav Dash Investments LTD transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Meitav Dash Investments LTD holds 40,000 shares of NRSN stock, worth $50,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,000
Previous 40,000
-0.0%
Holding current value
$50,400
Previous $37,000
105.41%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NRSN
# of Institutions
15Shares Held
443KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il149KShares$188,0460.0% of portfolio
-
Morgan Stanley New York, NY79.9KShares$100,6740.0% of portfolio
-
Squarepoint Ops LLC New York, NY49.9KShares$62,9050.0% of portfolio
-
Jane Street Group, LLC New York, NY28.7KShares$36,1480.0% of portfolio
-
Hrt Financial LP New York, NY21.7KShares$27,3340.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $14.7M